SCHEMBL20056927

SCHEMBL20056927

C[C@H]1C[C@@H](CCO)O[C@H]1n1cnc2c(=O)[nH]c(N)nc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HINT1 P49773 3/20 0.49
▸ HPGD P15428 1/20 0.49
▸ FUT5 Q11128 1/20 0.48
▸ STING1 Q86WV6 4/20 0.48
▸ PDE3B Q13370 1/20 0.48
▸ PDE3A Q14432 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ NT5E P21589 1/20 0.47
▸ TK1 P04183 1/20 0.46
▸ TAAR1 Q96RJ0 1/20 0.45
▸ USP2 O75604 1/20 0.45
▸ PNP P00491 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ EDNRA P25101 1/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ BLM P54132 1/20 0.45
▸ HBB P68871 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21562192 0.92 HPGD (0.52) HINT1HPGDFUT5STING1PDE3B
SCHEMBL20059041 0.92 HPGD (0.52) HINT1HPGDFUT5STING1PDE3B
SCHEMBL19035691 0.92 HPGD (0.52) HINT1HPGDFUT5STING1PDE3B
SCHEMBL19882058 0.92 HPGD (0.52) HINT1HPGDFUT5STING1PDE3B
SCHEMBL19242512 0.92 HPGD (0.52) HINT1HPGDFUT5STING1PDE3B
SCHEMBL23633225 0.89 ADORA3 (0.51) HINT1HPGDSTING1PDE3BPDE3A
SCHEMBL20057162 0.87 TAAR1 (0.49) HINT1HPGDFUT5STING1PDE3B
SCHEMBL6053627 0.81 STING1 (0.52) HINT1HPGDSTING1PDE3BPDE3A
SCHEMBL22869625 0.81 STING1 (0.52) HINT1HPGDSTING1PDE3BPDE3A
SCHEMBL8950587 0.81 STING1 (0.52) HINT1HPGDSTING1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935303-B1 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV JANSSEN BIOPHARMA INC (US) 2021-02-17 — — EP disclosed
EP-2655392-B1 CYCLIC NUCLEOTIDE ANALOGS ALIOS BIOPHARMA INC (US) 2018-04-18 — — EP disclosed
Send feedback